Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on December 14, 2016. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Transfection Kits

Closed
NIAID-NOI-17B1826265Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

Agency

N/A

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A

Full Description

Show more
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), Vaccine Research Center (VRC) intends to negotiate on an other than full and open competition basis with Life Technologies Corporation, 3175 Staley Road, Grand Island, New York 14072 to procure ExpiFectamine 293 Transfection Kit, size 10L, Catalog #A14525, qty-20 each. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106(b)(2) and 13.501(a)(1). Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type of contract. Delivery to Bethesda, Maryland 20892 approximately 10 days from date of award. The VRC has been using the ExpiFectamine 293 Transfection Kits for more than three (3) years. The kits is unique in that it allows for high density growth and protein production with the accompanied use of other 293Expi components such as specific cell lines. This has proven to support the production of the proteins that is required for protocols in the development for vaccines for HIV and other viruses. The kits are needed for ongoing experiments where the continuity of the ExpiFectamine 293 Transfection Kits must be maintained to ensure experimental results are not influenced by other variables. Failure to obtain the kits would result in the inability to perform experiments. Line Item#/Description/Quantity: 1) Expifectamine Transfection kit 10L, Catalog# A14525 Qty of 20 All responsible sources who feel they can meet these requirements shall submit their capabilities that will be considered. The government reserves the right to make a decision whether this requirement is available for competition. Offers must be submitted no later than 4:00 p.m. Eastern Time (ET), December 27 2016. Delivery address through the U.S. Postal Service, NIH/NIAID/AMOB, 5601 Fishers Lane, RM 3a64 Rockville, MD 20852. Electronic and fax quotations are not accepted. Requests for information concerning this requirement are to be addressed to Daniel Herdman at 240-669-5102 or herdmand@mail.nih.gov referencing the solicitation number. The vendor is responsible to confirm receipt of all quotations, emails and/or questions by the closing date of this announcement. Collect calls will not be accepted.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS